StockOtters
StockOttersSupply Chain Map
Komipharm International Co., Ltd. logo

Komipharm International Co., Ltd.

041960.KQ

Financial Statements

Income Statement (Annual)

Amounts in millions

2024

12/31/2024

Revenue
44
Cost of Revenue
28
Gross Profit
16
Gross Margin
37.0%
Operating Income
5
Operating Margin
10.5%
Net Income
10
Net Margin
22.3%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
16
EBITDA Margin
35.7%

2023

12/31/2023

Revenue
32
Cost of Revenue
22
Gross Profit
9
Gross Margin
29.7%
Operating Income
-5
Operating Margin
-14.7%
Net Income
-3
Net Margin
-9.3%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
0
EBITDA Margin
0.8%

2022

12/31/2022

Revenue
30
Cost of Revenue
21
Gross Profit
9
Gross Margin
28.8%
Operating Income
-3
Operating Margin
-9.6%
Net Income
-5
Net Margin
-16.4%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-1
EBITDA Margin
-3.6%

2021

12/31/2021

Revenue
27
Cost of Revenue
18
Gross Profit
8
Gross Margin
31.3%
Operating Income
-4
Operating Margin
-14.8%
Net Income
-3
Net Margin
-12.4%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-1
EBITDA Margin
-1.9%

2020

12/31/2020

Revenue
28
Cost of Revenue
18
Gross Profit
10
Gross Margin
36.0%
Operating Income
-2
Operating Margin
-5.9%
Net Income
-2
Net Margin
-7.6%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
1
EBITDA Margin
3.6%